1620 Investment Advisors’s Gilead Sciences GILD Stock Holding History

1620 Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$755K	Sell	5,976 -696	-10%	-$91.7K	0.47%	54
2026 Q1	$930K	Buy	6,672 +197	+3%	+$27.6K	0.63%	41
2025 Q4	$795K	Buy	6,475 +8	+0.1%	+$972	0.53%	51
2025 Q3	$718K	Sell	6,467 -57	-0.9%	-$6.48K	0.49%	62
2025 Q2	$723K	Buy	6,524 +263	+4%	+$28K	0.51%	54
2025 Q1	$702K	Buy	6,261 +76	+1%	+$7.84K	0.54%	48
2024 Q4	$571K	Buy	6,185 +338	+6%	+$30.4K	0.43%	70
2024 Q3	$490K	Sell	5,847 -25	-0.4%	-$1.91K	0.35%	86
2024 Q2	$403K	Buy	5,872 +3	+0.1%	+$200	0.31%	94
2024 Q1	$430K	Sell	5,869 -2,288	-28%	-$176K	0.43%	78
2023 Q4	$661K	Sell	8,157 -698	-8%	-$54.3K	0.72%	44
2023 Q3	$664K	Sell	8,855 -240	-3%	-$18.5K	0.75%	38
2023 Q2	$701K	Sell	9,095 -218	-2%	-$17.4K	0.76%	40
2023 Q1	$773K	Sell	9,313 -261	-3%	-$21.6K	0.93%	33
2022 Q4	$822K	Buy	+9,574	New	+$758K	1%	32
2022 Q2	–	Sell	-10,043	Closed	-$729K	–	130
2022 Q1	$729K	Hold	10,043	–	–	0.79%	43
2021 Q4	$729K	Buy	+10,043	New	+$692K	0.82%	43

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

1620 Investment Advisors's GILD Position: Q2 2026 in Review

1620 Investment Advisors reduced its Gilead Sciences (GILD) stake by 10% in Q2 2026, selling an estimated $91.7K and leaving 5,976 shares worth $755K. The position accounts for 0.47% of the portfolio, ranked #54.

1620 Investment Advisors first reported a position in GILD in Q4 2021 and has held it in 17 quarters since. The position peaked at $930K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

1620 Investment Advisors held 5,976 shares of Gilead Sciences worth $755K as of Q2 2026.
1620 Investment Advisors sold 696 Gilead Sciences shares in Q2 2026, an estimated $91.7K.
Gilead Sciences made up 0.47% of 1620 Investment Advisors's portfolio in Q2 2026, its #54 holding.
1620 Investment Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 17 quarters since.
1620 Investment Advisors's Gilead Sciences position peaked at $930K in Q1 2026.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.